Evidence map›Paper›PMID 22180617›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.

F Lynn Sonderegger, Ying Ma, Heather Maylor-Hagan, James Brewster, Xiaosong Huang, Gerald J Spangrude, James F Zachary, John H Weis, Janis J Weis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comparative transcriptome analysis ofFrontiers in cellular and infection microbiology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Immune Response toCurrent issues in molecular biology · 2021
    Article
  17. Innate Immune Memory to RepeatedJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

F Lynn SondereggerDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
Ying Ma
Heather Maylor-Hagan
James Brewster
Xiaosong Huang
Gerald J Spangrude
James F Zachary
John H Weis
Janis J Weis
University of Utah · USUniversity of Illinois Urbana-Champaign · US

Funding

MOLECULAR GENETICS OF LYME ARTHRITIS SUSCEPTIBILITYR01AR043521 · NIAMS · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1994 to 2024
$9.4M
BORRELIA BURGDORFERI MITOGEN IN DEVELOPMENT OF ARTHRITISR01AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1993 to 2023
$7.8M
Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
REGULATION OF CR2/CD21 EXPRESSION AND ACTIVATIONR01AI024158 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JOHN · 1987 to 2012
$3.5M
Salmonella Antimicrobial Peptide ResistanceR01AI043521 · NIAID · OHIO STATE UNIVERSITY · PI GUNN, JOHN S · 2004 to 2013
$3.1M
Role of Ifitm/Fragilis proteins as intracellular shuttles during cell activationR21AI088451 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JOHN · 2011 to 2012
$413k
SALMONELLA ANTIMICROBIAL PEPTIDE RESISTANCER29AI043521 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI GUNN, JOHN S · 1998 to 2002
$409k
Borrelia Burgdorferi Mitogen in Development of ArthritisR56AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 2013 to 2013
$350k
NIAID NIH HHS 5T32-AI-055434NIAID NIH HHS AI-088451NIAID NIH HHS AI-24158NIAID NIH HHS AI-32223NIAID NIH HHS AI-43521NIAID NIH HHS R01 AI024158NIAID NIH HHS R01 AI032223NIAID NIH HHS R01 AI043521NIAID NIH HHS R21 AI088451NIAID NIH HHS R29 AI043521NIAID NIH HHS R56 AI032223NIAID NIH HHS T32 AI055434NIAMS NIH HHS R01 AR043521
6 · The paper itself

Abstract

IL-10 is a nonredundant inflammatory modulator that suppresses arthritis development in Borrelia burgdorferi-infected mice. Infected C57BL/6 (B6) IL-10(-/-) mice were previously found to have a prolonged IFN-inducible response in joint tissue. Infection of B6 IL-10 reporter mice identified macrophages and CD4(+) T cells as the primary sources of IL-10 in the infected joint tissue, suggesting that early local production of IL-10 dampened the proarthritic IFN response. Treatment of B6 IL-10(-/-) mice with anti-IFN-γ reduced the increase in arthritis severity and suppressed IFN-inducible transcripts to wild-type levels, thereby linking dysregulation of IFN-γ to disease in the B6 IL-10(-/-) mouse. Arthritis in B6 IL-10(-/-) mice was associated with elevated numbers of NK cell, NKT cell, α/β T cell, and macrophage infiltration of the infected joint. FACS lineage sorting revealed NK cells and CD4(+) T cells as sources of IFN-γ in the joint tissue of B6 IL-10(-/-) mice. These findings suggest the presence of a positive-feedback loop in the joint tissue of infected B6 IL-10(-/-) mice, in which production of inflammatory chemokines, infiltration of IFN-γ-producing cells, and additional production of inflammatory cytokines result in arthritis. This mechanism of arthritis is in contrast to that seen in C3H/He mice, in which arthritis development is linked to transient production of type I IFN and develops independently of IFN-γ. Due to the sustained IFN response driven by NK cells and T cells, we propose the B6 IL-10(-/-) mouse as a potential model to study the persistent arthritis observed in some human Lyme disease patients.

Indexed as

AnimalsBorrelia burgdorferiCell MovementFeedback, PhysiologicalHumansInflammationInterferon-gammaInterleukin-10Killer Cells, NaturalLyme DiseaseMiceMice, KnockoutT-LymphocytesIL10 protein, mouseInterferon-gammaInterleukin-10

Identifiers

PMID22180617
PMCPMC3262892
OpenAlexW2136553001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.